SWOG clinical trial number
S1011

A Phase III Surgical Trial to Evaluate The Benefit Of A Standard Versus An Extended Pelvic Lymphadenectomy Performed At Time Of Radical Cystectomy For Muscle Invasive Urothelial Cancer

100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Abbreviated Title
Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III
Activated
08/01/2011
Closed
04/15/2017
Participants
Limited: Credentialed Surgeons Listed on S1011 Abstract Page

Research committees

Genitourinary Cancer

Treatment

Surgery

Other Clinical Trials

S2312
SWOG Clinical Trial Number
S2210
SWOG Clinical Trial Number
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
9% Accrual
Accrual
9%
Open
Phase
S2200
SWOG Clinical Trial Number
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
16% Accrual
Accrual
16%
Open
Phase